Study of Intramuscular Injections of OnabotulinumtoxinA to Assess Change in Disease Activity in Pediatric Participants With Spasticity Associated With Cerebral Palsy
Clinical trial NCT06150729 · COMPLETED
Trial details
- NCT number
- NCT06150729
- Sponsor
- AbbVie
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2023-09-08
- Primary completion
- 2025-05-30
- Enrollment
- 107
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.